Lyra Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Lyra Therapeutics

09/03/2022 14:11

* Lyra Therapeutics Inc  LYRA.OQ  reported a quarterly
adjusted
loss of $1.05​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 79 cents per share.
    * Revenue was $271.00 thousand​;  analysts expected $1.15
million. 
    * Lyra Therapeutics Inc's reported EPS for the quarter was a
loss
of $1.05​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lyra Therapeutics Inc shares had fallen by 1.4% this
quarter.
    * The company reported a quarterly loss of $13.62 million.
    * Wall Street's median 12-month price target for Lyra
Therapeutics
Inc is $24.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 9 at 02:11 p.m.  ​All
figures in US dollars unless otherwise stated